{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-111633","form_type":"8-K","ticker":"OVID","cik":"0001636651","company_name":"Ovid Therapeutics Inc.","filed_at":"2025-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.153641+00:00","generated_at":"2026-05-22T22:50:31.051590+00:00","sec_items":["5.08"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Ovid Therapeutics sets 2025 Annual Meeting for July 9; shareholder proposal deadline May 12","bullets":["Annual Meeting scheduled for July 9, 2025; record date for voting is May 19, 2025.","Shareholder proposals under Rule 14a-8 must be received by May 12, 2025.","Director nominations and other proposals under bylaws also due by May 12, 2025.","Meeting delayed more than 30 days from 2024 anniversary, triggering this 8-K notice.","Stockholders intending to use universal proxy rules must provide Rule 14a-19 notice by May 12, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-111633","json":"https://secwatch.observer/filing/0001193125-25-111633.json","markdown":"https://secwatch.observer/filing/0001193125-25-111633.md","text":"https://secwatch.observer/filing/0001193125-25-111633.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636651/000119312525111633/0001193125-25-111633-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636651/000119312525111633/d830663d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T22:50:31.051590+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}